Bios Clinical Opportunity Fund, LP - 10%+ Owner at Actuate Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
ACTU on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Bios Clinical Opportunity Fund, LP since 11/22/2023

Holdings reported by Bios Clinical Opportunity Fund, LP for Actuate Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 84.9K Aug 12, 2024 Directly held by BP Directors, LP
Common Stock 69.4K Aug 12, 2024 Directly held by Circle K Invesco, LP
Common Stock 61K Aug 12, 2024 Direct
Common Stock 8.06K Aug 12, 2024 Directly held by KF Legacy Trust U/A/D December 7, 2016
Common Stock 8.06K Aug 12, 2024 Directly held by MF Legacy Trust U/A/D December 7, 2016

There are no transactions reported by Bios Clinical Opportunity Fund, LP for Actuate Therapeutics, Inc.